Bafadhel, M., Sing, D., Jenkins, C., Peterson, S., Bengtsson, T., & Fageras, M. (2018). Late Breaking Abstract - Protection by budesonide against clinically important deteriorations (CID) in patients with COPD is dependent on blood eosinophil counts (EOS). European Respiratory Society.
芝加哥风格引文Bafadhel, M., D. Sing, C. Jenkins, S. Peterson, T. Bengtsson, 与 M. Fageras. Late Breaking Abstract - Protection by Budesonide Against Clinically Important Deteriorations (CID) in Patients with COPD Is Dependent on Blood Eosinophil Counts (EOS). European Respiratory Society, 2018.
MLA引文Bafadhel, M., et al. Late Breaking Abstract - Protection by Budesonide Against Clinically Important Deteriorations (CID) in Patients with COPD Is Dependent on Blood Eosinophil Counts (EOS). European Respiratory Society, 2018.